Literature DB >> 12928247

Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals.

Concetta Prontera, Michele Emdin, Gian Carlo Zucchelli, Andrea Ripoli, Claudio Passino, Aldo Clerico.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928247     DOI: 10.1373/49.9.1552

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.

Authors:  Luminita Voroneanu; Claudiu Cusai; Simona Hogas; Serban Ardeleanu; Mihai Onofriescu; Ionut Nistor; Octavian Prisada; Radu Sascau; David Goldsmith; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

2.  Mid-regional-pro-adrenomedullin plasma levels are increased in obese adolescents.

Authors:  Silvia Del Ry; Manuela Cabiati; Vanessa Bianchi; Laura Caponi; Pietro Di Cecco; Benedetta Marchi; Emioli Randazzo; Chiara Caselli; Tommaso Prescimone; Aldo Clerico; Giovanni Federico
Journal:  Eur J Nutr       Date:  2015-05-29       Impact factor: 5.614

3.  Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.

Authors:  M Feola; L Valeri; E Menditto; E Nervo; F Bianco; N Aspromonte; R Valle; G Visconti
Journal:  J Endocrinol Invest       Date:  2010-02-15       Impact factor: 4.256

4.  Prognostic value of alveolar volume in systolic heart failure: a prospective observational study.

Authors:  Massimo Miniati; Simonetta Monti; Matteo Bottai; Ivana Pavlickova; Claudio Passino; Michele Emdin; Roberta Poletti
Journal:  BMC Pulm Med       Date:  2013-11-22       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.